SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-110529
Filing Date
2014-03-21
Accepted
2014-03-21 17:02:38
Documents
13
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d630211d10k.htm 10-K 1248861
2 EX-21.1 d630211dex211.htm EX-21.1 2015
3 EX-23.1 d630211dex231.htm EX-23.1 1565
4 EX-31.1 d630211dex311.htm EX-31.1 10229
5 EX-31.2 d630211dex312.htm EX-31.2 10245
6 EX-32.1 d630211dex321.htm EX-32.1 4588
7 EX-32.2 d630211dex322.htm EX-32.2 4575
  Complete submission text file 0001193125-14-110529.txt   12751577

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT galt-20131231.xml EX-101.INS 1448778
9 XBRL TAXONOMY EXTENSION SCHEMA galt-20131231.xsd EX-101.SCH 106012
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20131231_cal.xml EX-101.CAL 59553
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20131231_def.xml EX-101.DEF 520211
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20131231_lab.xml EX-101.LAB 746569
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20131231_pre.xml EX-101.PRE 600359
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31791 | Film No.: 14710863
SIC: 2834 Pharmaceutical Preparations